The prevalence and antifolate drug resistance profiles of Plasmodium falciparum in study participants randomized to discontinue or continue cotrimoxazole prophylaxis.
Dennis W JumaPeninah MuiruriKrista YuhasGrace C John-StewartRonald OttichiloJohn WaitumbiBenson SingaChristina PolyakEdwin KamauPublished in: PLoS neglected tropical diseases (2019)
ClinicalTrials.gov NCT01425073.